HonCode

Go Back   HER2 Support Group Forums > her2group
Register Gallery FAQ Members List Calendar Today's Posts

Reply
 
Thread Tools Display Modes
Old 03-04-2011, 10:18 AM   #1
Lani
Senior Member
 
Join Date: Mar 2006
Posts: 4,778
Phase II trial results--herceptin + oral & IV vinorelbine for her2+Stage IV 1st line

ABSTRACT: A prospective multicenter phase II study of oral and i.v. vinorelbine plus trastuzumab as first-line therapy in HER2-overexpressing metastatic breast cancer
[Annals of Oncology]

Background: To evaluate the efficacy and safety of oral and i.v. vinorelbine plus trastuzumab as first-line regimen in a patient-convenient application for human epidermal growth factor receptor 2 (HER2)-overexpressing patients with metastatic breast cancer.

Patients and methods: Forty-two women were enrolled in a multicenter study. The patients received i.v. vinorelbine at a dose of 25 mg/m2 on day 1 followed by oral vinorelbine at a dose of 60 mg/m2 on days 8 and 15 in a 3-week cycle. Standard dose trastuzumab was given at 3-week intervals.

Results: Complete response was observed in 7 patients (18.9%) and partial response in 19 patients (51.4%), for an overall response rate of 70.3% [95% confidence interval (CI) 53.0-84.1]. The disease control rate reached 91.9% (95% CI 78.1-98.3). The median time to progression was 9.3 months, while median overall survival reached 35.6 months. Hematological and non-hematological toxic effects were acceptable with grade 3-4 leukopenia of 14% and neutropenia of 38%; cardiac toxicity did not reach the level of clinical relevance.

Conclusion: The combination of i.v. and oral vinorelbine plus trastuzumab demonstrates high activity and good tolerability in first-line treatment of HER2-overexpressing metastatic breast cancer. In addition, it offers convenience for the patients with only one i.v. treatment every 3 weeks.
Lani is offline   Reply With Quote
Old 03-04-2011, 10:38 AM   #2
Unregistered
Guest
 
Posts: n/a
Re: Phase II trial results--herceptin + oral & IV vinorelbine for her2+Stage IV 1st l

Quote:
while median overall survival reached 35.6 months
Please, could somebody say something about that data? It's understood that it is a median. But it means that 50% lived less then 3 years. But it was just a 1st line. Here of this site all people demonstrate better results and doing fine?
  Reply With Quote
Old 03-04-2011, 02:10 PM   #3
Lani
Senior Member
 
Join Date: Mar 2006
Posts: 4,778
Re: Phase II trial results--herceptin + oral & IV vinorelbine for her2+Stage IV 1st l

No I think you missed the point that these were Stage IV patients ie, those with distant metastases. Yes there are some on this board who have survived many years after becoming Stage IV--certainly not all

And for every person who participates in these discussions on her2suport there are scores who do not and are not as up-to-date on the latest being offered, what constitutes the "standard of care"(in countries who are trying to save healthcare dollars) as well as options to discuss with their oncologists.
Lani is offline   Reply With Quote
Old 03-05-2011, 05:23 AM   #4
Unregistered
Guest
 
Posts: n/a
Re: Phase II trial results--herceptin + oral & IV vinorelbine for her2+Stage IV 1st l

I lurked a lot and have read, compared the stats, learned the signatures, remembered and noticed, that since 2003 all fighters were alive not less than 5.5 years, except 5 angels.
  Reply With Quote
Old 03-05-2011, 06:43 AM   #5
pibikay
Senior Member
 
pibikay's Avatar
 
Join Date: May 2010
Posts: 432
Re: Phase II trial results--herceptin + oral & IV vinorelbine for her2+Stage IV 1st l

Thank you Lani
It is interesting and I hope it will be available in India soon
__________________
PBK
huband of Hema
Metstatic Breast Cancer Stage 4
Left breast cauliflower 25x20cm
ossousmetstatis in vertbrae secondaries L4=L5secondary
nodules in both liver lobes secondary
Diagnosed 10th March 2010
ER/PR-ve
Her 2 neu +++
Taxotrne Zylotec started 16th March
Herceptin added 5th April.9th Herceptin over on 20th Sep '10.Started on Tykerb and Xeloda on 22nd Oct2010TYKERB 4 TAB A DAY XELODA 4 TAB A DAY ONE WEEK ON ONE WEEK OFFZoletrust infusion every 4 months.Lesion in Brain 3D CRT Radiation started on 1st Feb'12 for 20 days ,5 days a week for 4 weeks.Devloped a small lump in breast.Xeloda stopped from 11th April '12.On Taxol.After 3 cycles of Taxol Taxol stopped.Back to Xeloda regime from 3rd July
Herceptin started again on 27th Dec 2012.Xeloda stopped Navelbin added on 7th February 2013.Now on Tykerb Herceptin and Navelbin
pibikay is offline   Reply With Quote
Old 03-05-2011, 07:44 AM   #6
Unregistered
Guest
 
Posts: n/a
Re: Phase II trial results--herceptin + oral & IV vinorelbine for her2+Stage IV 1st l

PBK,
Vinorelbine=Navelbine is not a new drug.
  Reply With Quote
Old 03-05-2011, 07:52 AM   #7
Lani
Senior Member
 
Join Date: Mar 2006
Posts: 4,778
Re: Phase II trial results--herceptin + oral & IV vinorelbine for her2+Stage IV 1st l

Unregistered? You must have spent a lot of time gathering that information and I would be interested for you to tabulate it and post it. I used to be able to easily find how many participants there were on this site, but no longer find it with ease. I also have trouble finding the personal histories portion of those who have registered ie, what stage they were, how treated etc I would to find in the past with more ease. However...

There are more than 2 million breast cancer survivors in the US alone out of a US population of 307 million, approximately half of them women (of course many of those are not in the years one normally gets bc ie, 0-20 year olds or commonly gets bc 20-40 year olds--and BRCA triple negative bc tends to be more common in the younger age groups than the ooder.

Since 20-25% of breast cancer is her2+, one could roughly estimate that 400,000 to 500,000 of those 2 million bc survivors are her2+ and a small minority of those are Stage IV. Even then, the number of registered members who post on this website probably make up 1-2 per cent of that ie, only one or two out of every one hundred her2+ breast cancer patients or their friends/families/caregivers posts here and many just lurk. And that is not the half or one-hundredth of it even.

There are 6.8 billion people worldwide--not all are female, nor all in the age groups that get bc, but let's suppose 2.7 billion are. Since the site is international, that would mean that only one or two out of every thousand or so bc patients posts on this site. How does one know when someone stops posting if they just got on with their life/ had other family members whose troubles took over much of their time vs. died of breast cancer vs died of other causes? or many other reasons

A much less time-consuming and more accurate/representative way to have a feel for what the statistics are for her2+ breast cancer, whether Stage I-III or Stage IV, is to look to the scientific literature. California itself has a fully funded agency to gather cancer statistics and it is far from being alone.

I had to Google to get the figures for the US population and World population. There are wonderful resources on the web and on this site for more accurate statistics. Her2 testing is not being performed worldwide, so we may never know how many her2+ breast cancer survivors there really are worldwide, but it can be inferred.

In the best of all possible worlds, all would be tested (and treated) and all have internet access, literacy, the ability to type in foreign languages and a feeling of responsibility to share their experiences with others to be added into the statistics (which would also enable them to be helped by the comradery, information and hope this site provides)
Lani is offline   Reply With Quote
Reply


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -7. The time now is 11:59 AM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter